Sun Pharmaceutical Industries Limited Press Release Sep 28 2026
Filed with NSE · · 6 pages · English
Summary by 6ix AI
Lerodalcibep has received EU approval and is indicated for lowering LDL cholesterol in patients with hypercholesterolemia. LIB Therapeutics will receive upfront and milestone payments, along with royalties based on net sales in the licensed territories.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Sun Pharmaceutical Industries' latest callSun Pharmaceutical Industries (NSE:SUNPHARMA) Q2 2027 Earnings Call · Replay · Oct 30Read the transcript of Sun Pharmaceutical Industries (NSE:SUNPHARMA) Q2 2027 Earnings CallSun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Sun Pharma Launches (C)Taro-Methylphenidate ER, the First and Only Bioequivalent to Concerta® with an Osmotic Delivery System
- First-Ever Standardized U.S. Treatment Recommendations Issued for Adults with Severe Alopecia Areata; Sun Pharma Welcomes Milestone
- Sun Pharma and Christian Siriano Launch "Regrowth Restyled" to Inspire Adults Living with Severe Alopecia Areata
- Sun Pharmaceutical Industries Limited Press Release Sep 01 2026
- Sun Pharmaceutical Industries Limited Press Release Jul 29 2026
Later from Sun Pharmaceutical Industries
- LIB Therapeutics and Sun Pharma Announce Global Licensing, Commercialization and Manufacturing Agreement for Lerodalcibep, a Novel PCSK9 Inhibitor, Ex-US and China; Lerodalcibep (Lyrokaul®) Approved in the EU
- Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 01, 2026, titled "New LEQSELVI® (deuruxolitinib) Two-YearData in Severe Alopecia Areata Showed Sustained Efficacy and Safety at EADV Congress 2026".
- Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care
- Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 20, 2026.
- Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 23, 2026.
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries